Oncotarget is an online open access, peer-reviewed journal serving the bio-medical community. Since its founding in 2010, the publication was solely focused on publishing papers and articles related to cancer care, treatment and research. Onotarget has since been embraced as such a valuable resource to the medical community that it has broadened its focus to include sections on aging, pathology, autophagy and cell death, chromosomes, immunology, micobiology and a host of other topics beyond Oncology. Demand for the information presented in Oncotarget has become so great that the formerly weekly journal is now published twice each week.
Published by Impact Journals, LLC, Oncotrget has an illustrious editorial board. Its editors-in-chief are noted educators, physicians and cancer researchers Mikhail Blagosklonny and Andrei Gudkov from Roswell Park Cancer Institute in New York. Nobel Prize winner Andrew V. Schally and Breakthrough Prize winners Stephen J. Elledge, Michael N. Hall, Alexander Varhavsky and Bert Vogelstein are Oncotarget ediorial board members. They have also published dozens of papers on groundbreaking topics in the publication. Oncotarget is widely read by medical professionals and has an Impact Factor of 5.168. Learn more about Oncotarget at Research Gate.
Currently the largest peer-reviewed oncology research publication in the world, the mission of Oncotarget is to disseminate information on scientific advances as widely and as quickly as possible. The publiction’s goal is to help people in the biomedical field get a deeper understanding of the accomplishments and breakthroughs that have been attained and to spur future roundbreaking discoveries. Oncotarget recently awarded travel grants to four biomedical researchers to enable them to visit Singapore for the ‘Frontiers in Cancer Science 2017’ conference. The conference will bring together the world’s top cancer experts to share information on exciting new research outcomes. Check Oncotarget journal at scimagojr.com
The researchers Oncotarget sponsored are Mohd Anas Shamsi of Aligarh Muslim University in India, Rajni Kumari and Ruhi Sandeep Deshmukh of India’s National Institute of Immunology and Vladan Milosevic of the University of Torino in Italy. An outstanding publicaton, Oncotarget is considered the most important journal in oncology and cancer research. It performs a crucial function for people working in cancer research and other important areas of medicine.